Citation:Lee DW, Kim KJ, Han SW, Lee HJ, Rhee YY, Bae JM, et al 2015

From Cancer Guidelines Wiki

Citation


Lee DW, Kim KJ, Han SW, Lee HJ, Rhee YY, Bae JM, et al. KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX. Ann Surg Oncol 2015 Jan;22(1):187-94 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24889488.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Optimal molecular profilingVictoria Freemancompleted
Optimal molecular profilingBen Lee-Batescompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Optimal molecular profiling